| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Sep'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Expenses | |||||||||||||
Research and development | |||||||||||||
3,525 | 4,348 | 3,885 | 4,216 | 3,167 | 2,802 | 1,914 | 1,525 | 1,520 | 1,088 | 1,355 | 446 | 319 | 241 |
General and administrative | |||||||||||||
2,421 | 1,807 | 1,457 | 1,674 | 1,527 | 1,416 | 1,058 | 924 | 757 | 411 | 738 | 269 | 146 | 81 |
Total operating expenses | |||||||||||||
5,946 | 6,155 | 5,342 | 5,890 | 4,694 | 4,218 | 2,972 | 2,449 | 2,277 | 1,499 | 2,093 | 715 | 465 | 322 |
Loss from operations | |||||||||||||
-5,946 | -6,155 | -5,342 | -5,890 | -4,694 | -4,218 | -2,972 | -2,449 | -2,277 | -1,499 | -2,093 | -715 | -465 | -322 |
Other Income | |||||||||||||
Interest and other income, net | |||||||||||||
605 | 798 | 1,070 | 542 | 583 | 510 | 217 | 173 | 127 | 105 | -3,180 | -44 | -29 | - |
Total interest and other income, net | |||||||||||||
- | - | - | 542 | - | - | - | 173 | 127 | 105 | -3,180 | -44 | -29 | - |
Net loss | |||||||||||||
-5,341 | -5,357 | -4,272 | -5,348 | -4,111 | -3,708 | -2,755 | -2,276 | -2,150 | - | - | - | -494 | -322 |
Unrealized gain on available-for-sale securities | |||||||||||||
14 | -1 | -7 | 2 | 14 | - | 3 | -2 | - | - | - | - | - | - |
Net loss applicable to stockholders and members | |||||||||||||
- | - | - | - | - | - | - | - | - | -1,394 | -5,273 | -759 | -494 | -322 |
Comprehensive loss | |||||||||||||
-5,327 | -5,358 | -4,279 | -5,346 | -4,097 | -3,707 | -2,752 | -2,278 | -2,150 | - | -5,273 | -759 | - | - |
Net loss per common share: Basic and diluted | |||||||||||||
-0.31 | -0.29 | -0.25 | -0.37 | -0.29 | -0.28 | -0.26 | -0.22 | -0.21 | 0.14 | -1.26 | -0.22 | -0.14 | -8.48 |
Weighted-average common shares outstanding: Basic and diluted | |||||||||||||
17,359 | 17,372 | 17,291 | 14,522 | 14,417 | 13,570 | 10,624 | 10,310 | 10,307 | 10,277 | 4,183 | 3,490 | 3,490 | 37 |